StoneX Group
TEVA icon

StoneX Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

StoneX Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,289
Closed -$115K – 713
2023
Q3 		$115K Buy
+11,289
New +$105K 0.01% 557

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ion Asset Management
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

StoneX Group's TEVA Position: Q4 2023 in Review

StoneX Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2023, closing a stake of 11,289 shares — an estimated $115K sold.

StoneX Group first reported a position in TEVA in Q3 2023 and held it in 1 quarter. The position peaked at $115K in Q3 2023. 448 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • StoneX Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2023 after selling out during the quarter.
  • StoneX Group sold 11,289 Teva Pharmaceutical Industries Limited shares in Q4 2023, an estimated $115K.
  • StoneX Group first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and held it in 1 quarter.
  • StoneX Group's Teva Pharmaceutical Industries Limited position peaked at $115K in Q3 2023.
  • 448 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2023.

Based on StoneX Group's 13F filing for Q4 2023, filed 12 Feb 2024.